Medipost Co (XKRX:078160) Accounts Payable & Accrued Expense : ₩6,018 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Medipost Co Accounts Payable & Accrued Expense?

Medipost Co's quarterly accounts payable & accrued expense declined from Jun. 2023 (₩7,949 Mil) to Sep. 2023 (₩7,699 Mil) and declined from Sep. 2023 (₩7,699 Mil) to Dec. 2023 (₩6,018 Mil).

Medipost Co's annual accounts payable & accrued expense increased from Dec. 2021 (₩5,047 Mil) to Dec. 2022 (₩7,225 Mil) but then declined from Dec. 2022 (₩7,225 Mil) to Dec. 2023 (₩6,018 Mil).

Medipost Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Medipost Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Accounts Payable & Accrued Expense Chart

Medipost Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6,282.57

4,465.93

5,047.02

7,225.10

6,018.12

Medipost Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															7,225.10	6,544.26	7,949.38	7,699.15	6,018.12

Medipost Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Medipost Co (XKRX:078160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines